nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofedanol—Benzphetamine—obesity	0.561	1	CrCtD
Clofedanol—Toremifene—Benzphetamine—obesity	0.0267	0.0647	CrCrCtD
Clofedanol—Naftifine—Benzphetamine—obesity	0.0221	0.0536	CrCrCtD
Clofedanol—Alverine—Benzphetamine—obesity	0.0212	0.0514	CrCrCtD
Clofedanol—Isopropamide—Benzphetamine—obesity	0.0212	0.0514	CrCrCtD
Clofedanol—Phenprocoumon—Benzphetamine—obesity	0.0204	0.0494	CrCrCtD
Clofedanol—Tamoxifen—Benzphetamine—obesity	0.0183	0.0444	CrCrCtD
Clofedanol—Antazoline—Benzphetamine—obesity	0.0183	0.0444	CrCrCtD
Clofedanol—Methadyl Acetate—Benzphetamine—obesity	0.0177	0.043	CrCrCtD
Clofedanol—Levomethadyl Acetate—Benzphetamine—obesity	0.0177	0.043	CrCrCtD
Clofedanol—Cyclobenzaprine—Benzphetamine—obesity	0.0167	0.0404	CrCrCtD
Clofedanol—Doxylamine—Benzphetamine—obesity	0.0153	0.0372	CrCrCtD
Clofedanol—Phenoxybenzamine—Benzphetamine—obesity	0.0146	0.0353	CrCrCtD
Clofedanol—Diphenidol—Benzphetamine—obesity	0.0146	0.0353	CrCrCtD
Clofedanol—Dextropropoxyphene—Benzphetamine—obesity	0.0146	0.0353	CrCrCtD
Clofedanol—Atomoxetine—Benzphetamine—obesity	0.0139	0.0336	CrCrCtD
Clofedanol—Tripelennamine—Benzphetamine—obesity	0.0139	0.0336	CrCrCtD
Clofedanol—Trimipramine—Benzphetamine—obesity	0.0135	0.0328	CrCrCtD
Clofedanol—Bromodiphenhydramine—Benzphetamine—obesity	0.013	0.0314	CrCrCtD
Clofedanol—Benzphetamine—Methamphetamine—obesity	0.0128	0.0311	CrCrCtD
Clofedanol—Pheniramine—Benzphetamine—obesity	0.0127	0.0308	CrCrCtD
Clofedanol—Methadone—Benzphetamine—obesity	0.0122	0.0295	CrCrCtD
Clofedanol—Promethazine—Benzphetamine—obesity	0.0115	0.0279	CrCrCtD
Clofedanol—Alimemazine—Benzphetamine—obesity	0.0113	0.0274	CrCrCtD
Clofedanol—Orphenadrine—Benzphetamine—obesity	0.0102	0.0247	CrCrCtD
Clofedanol—Promazine—Benzphetamine—obesity	0.00972	0.0236	CrCrCtD
Clofedanol—Benzyl Benzoate—Benzphetamine—obesity	0.00944	0.0229	CrCrCtD
Clofedanol—Diphenhydramine—Benzphetamine—obesity	0.00905	0.0219	CrCrCtD
Clofedanol—Atomoxetine—NPY1R—obesity	0.000241	0.0777	CrCbGaD
Clofedanol—Loperamide—POMC—obesity	0.000163	0.0526	CrCbGaD
Clofedanol—Tamoxifen—CES1—obesity	0.000131	0.0423	CrCbGaD
Clofedanol—Amitriptyline—NTRK2—obesity	0.000124	0.04	CrCbGaD
Clofedanol—Captodiame—HTR2C—obesity	0.000113	0.0363	CrCbGaD
Clofedanol—Disopyramide—SLC22A1—obesity	9.96e-05	0.0321	CrCbGaD
Clofedanol—Toremifene—ESR1—obesity	8.23e-05	0.0265	CrCbGaD
Clofedanol—Chlorphenamine—SLC22A1—obesity	7.27e-05	0.0234	CrCbGaD
Clofedanol—Levomethadyl Acetate—CYP19A1—obesity	6.04e-05	0.0194	CrCbGaD
Clofedanol—Clotrimazole—CYP19A1—obesity	6.04e-05	0.0194	CrCbGaD
Clofedanol—Phenoxybenzamine—SLC22A1—obesity	5.88e-05	0.0189	CrCbGaD
Clofedanol—Tamoxifen—ESR2—obesity	5.33e-05	0.0172	CrCbGaD
Clofedanol—Atomoxetine—HTR1B—obesity	5.24e-05	0.0169	CrCbGaD
Clofedanol—Diphenhydramine—SLC22A1—obesity	4.93e-05	0.0159	CrCbGaD
Clofedanol—Carbinoxamine—CYP2E1—obesity	4.74e-05	0.0153	CrCbGaD
Clofedanol—Cyclobenzaprine—HTR2A—obesity	4.63e-05	0.0149	CrCbGaD
Clofedanol—Clotrimazole—CYP2E1—obesity	4.5e-05	0.0145	CrCbGaD
Clofedanol—Chlorprothixene—DRD1—obesity	4.44e-05	0.0143	CrCbGaD
Clofedanol—Atomoxetine—HTR2C—obesity	4.27e-05	0.0137	CrCbGaD
Clofedanol—Chlorphenamine—SLC6A4—obesity	4.21e-05	0.0136	CrCbGaD
Clofedanol—Promazine—DRD4—obesity	4.11e-05	0.0132	CrCbGaD
Clofedanol—Brompheniramine—CYP2E1—obesity	4.1e-05	0.0132	CrCbGaD
Clofedanol—Clomipramine—HTR2C—obesity	3.82e-05	0.0123	CrCbGaD
Clofedanol—Chlorprothixene—HTR2C—obesity	3.8e-05	0.0122	CrCbGaD
Clofedanol—Phenoxybenzamine—ADRB2—obesity	3.75e-05	0.0121	CrCbGaD
Clofedanol—Chlorpromazine—SLC22A1—obesity	3.74e-05	0.0121	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—PMCH—obesity	3.72e-05	0.0016	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—NPY5R—obesity	3.72e-05	0.0016	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—NMU—obesity	3.72e-05	0.0016	CbGpPWpGaD
Clofedanol—Imipramine—SLC22A1—obesity	3.72e-05	0.012	CrCbGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—obesity	3.67e-05	0.00158	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—obesity	3.67e-05	0.00158	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—KIF7—obesity	3.65e-05	0.00157	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MKS1—obesity	3.65e-05	0.00157	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—NPS—obesity	3.63e-05	0.00156	CbGpPWpGaD
Clofedanol—Chlorpromazine—DRD4—obesity	3.61e-05	0.0116	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—NPY2R—obesity	3.57e-05	0.00153	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—MC4R—obesity	3.57e-05	0.00153	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—NPY1R—obesity	3.57e-05	0.00153	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—MC3R—obesity	3.57e-05	0.00153	CbGpPWpGaD
Clofedanol—Tamoxifen—CYP19A1—obesity	3.57e-05	0.0115	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—DRD1—obesity	3.56e-05	0.00153	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR2C—obesity	3.56e-05	0.00153	CbGpPWpGaD
Clofedanol—Methadone—CYP19A1—obesity	3.54e-05	0.0114	CrCbGaD
Clofedanol—Atomoxetine—SLC6A4—obesity	3.54e-05	0.0114	CrCbGaD
Clofedanol—Trimipramine—HTR2C—obesity	3.51e-05	0.0113	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—PPY—obesity	3.5e-05	0.00151	CbGpPWpGaD
Clofedanol—Promazine—DRD1—obesity	3.48e-05	0.0112	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—ADRB1—obesity	3.45e-05	0.00148	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GIP—obesity	3.44e-05	0.00148	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—PRKCH—obesity	3.44e-05	0.00148	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—obesity	3.39e-05	0.00146	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—NPY5R—obesity	3.38e-05	0.00145	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—HCRT—obesity	3.38e-05	0.00145	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PMCH—obesity	3.38e-05	0.00145	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—NMU—obesity	3.38e-05	0.00145	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—GHRL—obesity	3.37e-05	0.00145	CbGpPWpGaD
Clofedanol—Doxepin—HTR2C—obesity	3.35e-05	0.0108	CrCbGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—obesity	3.35e-05	0.00144	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—DRD4—obesity	3.35e-05	0.00144	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PRLH—obesity	3.33e-05	0.00143	CbGpPWpGaD
Clofedanol—Tamoxifen—ESR1—obesity	3.29e-05	0.0106	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—obesity	3.25e-05	0.0014	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—MC3R—obesity	3.24e-05	0.00139	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—NPY1R—obesity	3.24e-05	0.00139	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—MC4R—obesity	3.24e-05	0.00139	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—NPY2R—obesity	3.24e-05	0.00139	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CNR1—obesity	3.19e-05	0.00137	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PPY—obesity	3.18e-05	0.00137	CbGpPWpGaD
Clofedanol—Amitriptyline—HTR1B—obesity	3.17e-05	0.0102	CrCbGaD
Clofedanol—Clomipramine—SLC6A4—obesity	3.16e-05	0.0102	CrCbGaD
Clofedanol—Chlorprothixene—DRD2—obesity	3.13e-05	0.0101	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—GIP—obesity	3.12e-05	0.00134	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PRKCH—obesity	3.12e-05	0.00134	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—DRD2—obesity	3.12e-05	0.00134	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—GCG—obesity	3.08e-05	0.00133	CbGpPWpGaD
Clofedanol—Chlorpromazine—DRD1—obesity	3.06e-05	0.00985	CrCbGaD
Clofedanol—HRH1—G alpha (q) signalling events—PIK3R1—obesity	3.01e-05	0.0013	CbGpPWpGaD
Clofedanol—Phenprocoumon—ALB—obesity	2.98e-05	0.00959	CrCbGaD
Clofedanol—Promazine—HTR2C—obesity	2.97e-05	0.00958	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—ADRB3—obesity	2.92e-05	0.00126	CbGpPWpGaD
Clofedanol—Trimipramine—SLC6A4—obesity	2.91e-05	0.00937	CrCbGaD
Clofedanol—Trimipramine—DRD2—obesity	2.89e-05	0.00932	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—obesity	2.87e-05	0.00123	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—obesity	2.86e-05	0.00123	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GAL—obesity	2.85e-05	0.00123	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—C5AR1—obesity	2.82e-05	0.00121	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—ADRB2—obesity	2.79e-05	0.0012	CbGpPWpGaD
Clofedanol—Promethazine—DRD2—obesity	2.79e-05	0.00897	CrCbGaD
Clofedanol—Chlorpromazine—BCHE—obesity	2.78e-05	0.00895	CrCbGaD
Clofedanol—Doxepin—SLC6A4—obesity	2.77e-05	0.00893	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—GHRH—obesity	2.76e-05	0.00119	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NMB—obesity	2.76e-05	0.00119	CbGpPWpGaD
Clofedanol—Doxepin—DRD2—obesity	2.76e-05	0.00888	CrCbGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—obesity	2.75e-05	0.00118	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—obesity	2.72e-05	0.00117	CbGpPWpGaD
Clofedanol—Atomoxetine—HTR2A—obesity	2.72e-05	0.00876	CrCbGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—obesity	2.7e-05	0.00116	CbGpPWpGaD
Clofedanol—Tamoxifen—CYP2E1—obesity	2.66e-05	0.00858	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—GNB3—obesity	2.66e-05	0.00114	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—ADRB3—obesity	2.65e-05	0.00114	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—FFAR4—obesity	2.64e-05	0.00113	CbGpPWpGaD
Clofedanol—Chlorpromazine—HTR2C—obesity	2.62e-05	0.00843	CrCbGaD
Clofedanol—Imipramine—HTR2C—obesity	2.6e-05	0.00839	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—GAL—obesity	2.59e-05	0.00111	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—GNAS—obesity	2.59e-05	0.00111	CbGpPWpGaD
Clofedanol—Amitriptyline—HTR2C—obesity	2.59e-05	0.00833	CrCbGaD
Clofedanol—Orphenadrine—CYP2E1—obesity	2.59e-05	0.00833	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—CCK—obesity	2.58e-05	0.00111	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—C5AR1—obesity	2.56e-05	0.0011	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—BRS3—obesity	2.53e-05	0.00109	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MCHR1—obesity	2.53e-05	0.00109	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GHSR—obesity	2.53e-05	0.00109	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GLP1R—obesity	2.52e-05	0.00108	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—obesity	2.51e-05	0.00108	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CCL5—obesity	2.48e-05	0.00106	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CCKAR—obesity	2.47e-05	0.00106	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—HRH3—obesity	2.47e-05	0.00106	CbGpPWpGaD
Clofedanol—Promazine—DRD2—obesity	2.45e-05	0.00789	CrCbGaD
Clofedanol—Clomipramine—HTR2A—obesity	2.43e-05	0.00783	CrCbGaD
Clofedanol—Chlorprothixene—HTR2A—obesity	2.42e-05	0.00779	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—PRLHR—obesity	2.35e-05	0.00101	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SH2B1—obesity	2.35e-05	0.00101	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GH1—obesity	2.35e-05	0.00101	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CCK—obesity	2.34e-05	0.00101	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	2.29e-05	0.000984	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GLP1R—obesity	2.28e-05	0.000982	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CCKAR—obesity	2.25e-05	0.000966	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—HRH3—obesity	2.25e-05	0.000966	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—NPY—obesity	2.24e-05	0.000964	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	2.24e-05	0.000963	CbGpPWpGaD
Clofedanol—Trimipramine—HTR2A—obesity	2.24e-05	0.0072	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—IAPP—obesity	2.23e-05	0.000958	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—APLN—obesity	2.21e-05	0.00095	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PYY—obesity	2.21e-05	0.00095	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR2A—obesity	2.18e-05	0.000938	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—C3—obesity	2.18e-05	0.000937	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PRKAR2B—obesity	2.16e-05	0.00093	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CRH—obesity	2.16e-05	0.00093	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR1B—obesity	2.16e-05	0.00093	CbGpPWpGaD
Clofedanol—Imipramine—SLC6A4—obesity	2.16e-05	0.00695	CrCbGaD
Clofedanol—Chlorpromazine—DRD2—obesity	2.16e-05	0.00695	CrCbGaD
Clofedanol—Promethazine—HTR2A—obesity	2.15e-05	0.00693	CrCbGaD
Clofedanol—Imipramine—DRD2—obesity	2.15e-05	0.00691	CrCbGaD
Clofedanol—Amitriptyline—SLC6A4—obesity	2.14e-05	0.00691	CrCbGaD
Clofedanol—Amitriptyline—DRD2—obesity	2.13e-05	0.00687	CrCbGaD
Clofedanol—Doxepin—HTR2A—obesity	2.13e-05	0.00686	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—PNLIP—obesity	2.09e-05	0.0009	CbGpPWpGaD
Clofedanol—Chlorpromazine—CYP2E1—obesity	2.08e-05	0.00669	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—AGT—obesity	2.07e-05	0.00089	CbGpPWpGaD
Clofedanol—Imipramine—CYP2E1—obesity	2.06e-05	0.00665	CrCbGaD
Clofedanol—Amitriptyline—CYP2E1—obesity	2.05e-05	0.00661	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—NPS—obesity	2.05e-05	0.000882	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SDC3—obesity	2.04e-05	0.000879	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—NPY—obesity	2.04e-05	0.000875	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—IAPP—obesity	2.02e-05	0.00087	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—DRD1—obesity	2.01e-05	0.000865	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR2C—obesity	2.01e-05	0.000865	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NPY5R—obesity	2e-05	0.000859	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HCRT—obesity	2e-05	0.000859	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PMCH—obesity	2e-05	0.000859	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NMU—obesity	2e-05	0.000859	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—HTR1B—obesity	1.96e-05	0.000844	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CRH—obesity	1.96e-05	0.000844	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—ADRB1—obesity	1.95e-05	0.000837	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NPY2R—obesity	1.91e-05	0.000823	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NPY1R—obesity	1.91e-05	0.000823	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MC4R—obesity	1.91e-05	0.000823	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MC3R—obesity	1.91e-05	0.000823	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—F2—obesity	1.91e-05	0.000823	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GHRL—obesity	1.91e-05	0.00082	CbGpPWpGaD
Clofedanol—Promazine—HTR2A—obesity	1.89e-05	0.0061	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—DRD4—obesity	1.89e-05	0.000813	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PPY—obesity	1.88e-05	0.000807	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—NPS—obesity	1.86e-05	0.000801	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PRKCH—obesity	1.84e-05	0.000793	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HDAC8—obesity	1.84e-05	0.000793	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GIP—obesity	1.84e-05	0.000793	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—HTR2C—obesity	1.83e-05	0.000785	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—DRD1—obesity	1.83e-05	0.000785	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CNR1—obesity	1.81e-05	0.000776	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—ADRB1—obesity	1.77e-05	0.00076	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—DRD2—obesity	1.76e-05	0.000757	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—LEPR—obesity	1.75e-05	0.000753	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GCG—obesity	1.74e-05	0.00075	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—POMC—obesity	1.74e-05	0.000749	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GHRL—obesity	1.73e-05	0.000744	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—DRD4—obesity	1.72e-05	0.000738	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CCL2—obesity	1.71e-05	0.000733	CbGpPWpGaD
Clofedanol—HRH1—G alpha (q) signalling events—PIK3CA—obesity	1.7e-05	0.000729	CbGpPWpGaD
Clofedanol—Chlorpromazine—HTR2A—obesity	1.67e-05	0.00537	CrCbGaD
Clofedanol—Clomipramine—ALB—obesity	1.66e-05	0.00536	CrCbGaD
Clofedanol—Imipramine—HTR2A—obesity	1.66e-05	0.00534	CrCbGaD
Clofedanol—Amitriptyline—HTR2A—obesity	1.65e-05	0.00531	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—CNR1—obesity	1.64e-05	0.000705	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—DRD2—obesity	1.6e-05	0.000688	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GCG—obesity	1.58e-05	0.000681	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—ADRB2—obesity	1.58e-05	0.000678	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ADRB3—obesity	1.57e-05	0.000674	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GAL—obesity	1.53e-05	0.000658	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—obesity	1.52e-05	0.000652	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—C5AR1—obesity	1.51e-05	0.000651	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GNB3—obesity	1.5e-05	0.000646	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GNAS—obesity	1.46e-05	0.000629	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—ADRB2—obesity	1.43e-05	0.000616	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CCL5—obesity	1.4e-05	0.000602	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PRKG1—obesity	1.38e-05	0.000595	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCK—obesity	1.38e-05	0.000595	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GNB3—obesity	1.36e-05	0.000587	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—RBP4—obesity	1.35e-05	0.00058	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GLP1R—obesity	1.35e-05	0.00058	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—obesity	1.34e-05	0.000578	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GNAS—obesity	1.33e-05	0.000571	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCKAR—obesity	1.33e-05	0.000571	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HRH3—obesity	1.33e-05	0.000571	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PRKAR2B—obesity	1.28e-05	0.000549	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CCL5—obesity	1.27e-05	0.000546	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—PRKCD—obesity	1.26e-05	0.000542	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NCF2—obesity	1.23e-05	0.000531	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR2A—obesity	1.23e-05	0.00053	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—C3—obesity	1.23e-05	0.00053	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NPY—obesity	1.2e-05	0.000517	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—IAPP—obesity	1.2e-05	0.000514	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—APOC3—obesity	1.2e-05	0.000514	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—AGT—obesity	1.17e-05	0.000503	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CRH—obesity	1.16e-05	0.000499	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR1B—obesity	1.16e-05	0.000499	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SDC1—obesity	1.15e-05	0.000493	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PRKCD—obesity	1.14e-05	0.000492	CbGpPWpGaD
Clofedanol—Chlorpromazine—ALB—obesity	1.14e-05	0.00367	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—AKR1C3—obesity	1.13e-05	0.000485	CbGpPWpGaD
Clofedanol—Amitriptyline—ALB—obesity	1.13e-05	0.00363	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—HTR2A—obesity	1.12e-05	0.000482	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—C3—obesity	1.12e-05	0.000481	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NPS—obesity	1.1e-05	0.000473	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—F2—obesity	1.08e-05	0.000465	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—PRKCB—obesity	1.08e-05	0.000465	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—DRD1—obesity	1.08e-05	0.000464	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR2C—obesity	1.08e-05	0.000464	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—AGT—obesity	1.06e-05	0.000457	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NTRK2—obesity	1.05e-05	0.000451	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ADRB1—obesity	1.04e-05	0.000449	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—PIK3CG—obesity	1.03e-05	0.000445	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PARP1—obesity	1.02e-05	0.00044	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GHRL—obesity	1.02e-05	0.00044	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—DRD4—obesity	1.01e-05	0.000436	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—POMC—obesity	9.85e-06	0.000424	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PRKCB—obesity	9.82e-06	0.000422	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—F2—obesity	9.82e-06	0.000422	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CNR1—obesity	9.68e-06	0.000416	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—TCF7L2—obesity	9.51e-06	0.000409	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—AKT2—obesity	9.47e-06	0.000407	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—DRD2—obesity	9.45e-06	0.000406	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PIK3CG—obesity	9.4e-06	0.000404	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GCG—obesity	9.35e-06	0.000402	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PTPN1—obesity	9.35e-06	0.000402	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—PIK3CD—obesity	9.1e-06	0.000391	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—POMC—obesity	8.95e-06	0.000385	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PRL—obesity	8.92e-06	0.000384	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—STK11—obesity	8.79e-06	0.000378	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CCL2—obesity	8.75e-06	0.000376	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PLG—obesity	8.69e-06	0.000374	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—RHOA—obesity	8.68e-06	0.000373	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—AKT2—obesity	8.6e-06	0.00037	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—PIK3R1—obesity	8.59e-06	0.000369	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—FOXO3—obesity	8.49e-06	0.000365	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ADRB2—obesity	8.46e-06	0.000364	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SOCS1—obesity	8.34e-06	0.000358	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PIK3CD—obesity	8.26e-06	0.000355	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SOCS3—obesity	8.23e-06	0.000354	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GNB3—obesity	8.06e-06	0.000347	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—TYK2—obesity	7.95e-06	0.000342	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—PIK3CB—obesity	7.93e-06	0.000341	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—IGF2—obesity	7.92e-06	0.00034	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—RHOA—obesity	7.88e-06	0.000339	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GNAS—obesity	7.85e-06	0.000337	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PIK3R1—obesity	7.8e-06	0.000335	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—APOB—obesity	7.69e-06	0.00033	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCL5—obesity	7.51e-06	0.000323	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—LPL—obesity	7.34e-06	0.000316	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—FOXO1—obesity	7.29e-06	0.000313	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—RPS6KB1—obesity	7.27e-06	0.000313	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PIK3CB—obesity	7.2e-06	0.00031	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PRKCD—obesity	6.76e-06	0.000291	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR2A—obesity	6.62e-06	0.000284	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—C3—obesity	6.61e-06	0.000284	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—IRS2—obesity	6.29e-06	0.00027	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—AGT—obesity	6.28e-06	0.00027	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—LEP—obesity	6.15e-06	0.000264	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—APOE—obesity	6.15e-06	0.000264	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CAV1—obesity	6.09e-06	0.000262	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—APOA1—obesity	6.08e-06	0.000261	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ESR1—obesity	5.87e-06	0.000253	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—F2—obesity	5.8e-06	0.000249	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PRKCB—obesity	5.8e-06	0.000249	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—BAD—obesity	5.73e-06	0.000246	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PIK3CG—obesity	5.55e-06	0.000239	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—IRS1—obesity	5.49e-06	0.000236	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—POMC—obesity	5.28e-06	0.000227	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—INS—obesity	5.26e-06	0.000226	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCL2—obesity	5.17e-06	0.000222	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—IGF1—obesity	5.08e-06	0.000219	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—AKT2—obesity	5.08e-06	0.000218	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PIK3CD—obesity	4.88e-06	0.00021	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—PIK3CA—obesity	4.83e-06	0.000208	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SERPINE1—obesity	4.83e-06	0.000208	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—TYK2—obesity	4.69e-06	0.000202	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—RHOA—obesity	4.66e-06	0.0002	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PIK3R1—obesity	4.61e-06	0.000198	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NOS3—obesity	4.61e-06	0.000198	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PIK3CA—obesity	4.39e-06	0.000189	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MTOR—obesity	4.25e-06	0.000183	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PIK3CB—obesity	4.25e-06	0.000183	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—AKT1—obesity	3.95e-06	0.00017	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—IL6—obesity	3.89e-06	0.000167	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MMP9—obesity	3.7e-06	0.000159	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MAPK8—obesity	3.6e-06	0.000155	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—AKT1—obesity	3.59e-06	0.000154	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—STAT3—obesity	3.29e-06	0.000141	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MYC—obesity	3.05e-06	0.000131	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—TGFB1—obesity	3.05e-06	0.000131	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PIK3CA—obesity	2.59e-06	0.000111	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—IL6—obesity	2.3e-06	9.87e-05	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—AKT1—obesity	2.12e-06	9.11e-05	CbGpPWpGaD
